Unknown

Dataset Information

Systemic treatment type is not associated with abnormal post-treatment noninvasive liver stiffness measurement in psoriasis.


ABSTRACT:

Background

Psoriasis is commonly associated with metabolic dysfunction-associated steatotic liver disease, raising concerns about the hepatic effects of systemic treatments on psoriasis and its comorbid conditions. This study evaluates liver stiffness measurement (LSM) alterations and identifies predictors of abnormal LSM in psoriatic patients following systemic treatments, including biologics and methotrexate.

Methods

This prospective cohort study is based on the PSOWCH database (Psoriasis Cohort of West China Hospital). We initially included psoriatic patients who had undergone sound touch elastography (STE), then recruited patients who had STE before systemic treatment and reassessed them after at least six months. Three treatment subgroups were formed (interleukin inhibi

SUBMITTER: Xiao Y 

PROVIDER: S-EPMC11670192 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature